Welcome to Lundbeck Inc.

Lundbeck Inc. is committed to providing innovative therapies that fulfill unmet medical needs of people with severe, and often rare, diseases for which few, if any, effective treatments are available.


Recent News

July 30, 2010
Lundbeck Inc. Announces the Voluntary Nationwide Recall of Two Lots of NeoProfen® (ibuprofen lysine) Injection

May 25, 2010
Lundbeck Will Submit an NDA for Clobazam for Patients with Lennox-Gastaut Syndrome with the FDA Before Year End 2010

May 19, 2010
Lundbeck Inc. Receives 2010 Corporate Award from National Organization for Rare Disorders


Read more

 
This site contains medical information that is intended for residents of the United States only and is not meant to
substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns.
Use and access of this site is subject to the terms and conditions as set out in our Privacy Policy and Terms of Use.
© Copyright 2010 Lundbeck Inc. All rights reserved.
Phone: 866-337-6996
Fax: 847.282.1001
contact@lundbeck.com